Log in
Enquire now
‌

US Patent 7396796 Treatment agent, method and device for treating hazardous substances

Patent 7396796 was granted and assigned to Noritake Co., Inc. on July, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Noritake Co., Inc.
Noritake Co., Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
73967960
Patent Inventor Names
Hisanori Kurobe0
Shinji Kato0
Misao Iwata0
Hirokazu Watanabe0
Koushi Yamaguchi0
Date of Patent
July 8, 2008
0
Patent Application Number
103444920
Date Filed
October 3, 2001
0
Patent Primary Examiner
‌
Jerry Lorengo
0
Patent abstract

A hazardous substance treatment agent has a retainer and a transition metal oxide. The retainer has the specificity of retaining only a specific hazardous substance, such as a virus, a bacterium or a toxin, that has become mixed in or has the possibility of becoming mixed in a treatment subject, such as blood, that is in at least either a liquid or gaseous phase. By a photocatalytic action, the transition metal oxide inactivates said hazardous substance retained by the retainer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7396796 Treatment agent, method and device for treating hazardous substances

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.